Evidence map›Paper›PMID 30924861›Full record

ArticleJournal of medical entomology2019

Plasmodium falciparum (Haemosporodia: Plasmodiidae) and O'nyong-nyong Virus Development in a Transgenic Anopheles gambiae (Diptera: Culicidae) Strain.

John D Mumford, Carole A Long, Scott C Weaver, Katzutoyo Miura, Eryu Wang, Rachel Rotenberry, Ellen M Dotson, Mark Q Benedict

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical entomology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. A Systematic Review on the Viruses ofTropical medicine and infectious disease · 2023
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

John D MumfordImperial College London, Centre for Environmental Policy, Silwood Park Campus, Ascot, Berkshire, UK.
Carole A LongNIH, NIAID, Laboratory of Malaria and Vector Research, Malaria Immunology Section, Twinbrook Pkwy, Rockville, MD.
Scott C WeaverInstitute for Human Infections and Immunity and Department of Microbiology & Immunology, University of Texas Medical Branch (UTMB), Galveston, TX.
Katzutoyo MiuraNIH, NIAID, Laboratory of Malaria and Vector Research, Malaria Immunology Section, Twinbrook Pkwy, Rockville, MD.
Eryu WangInstitute for Human Infections and Immunity and Department of Microbiology & Immunology, University of Texas Medical Branch (UTMB), Galveston, TX.
Rachel RotenberryCenters for Disease Control and Prevention, DPDM/Entomology Branch, Atlanta, GA.
Ellen M DotsonCenters for Disease Control and Prevention, DPDM/Entomology Branch, Atlanta, GA.
Mark Q BenedictCenters for Disease Control and Prevention, DPDM/Entomology Branch, Atlanta, GA.
Centers for Disease Control and Prevention · USThe University of Texas Medical Branch at Galveston · USVector Oncology (United States) · USImperial College London · GB

Funding

Host Immune Responses to Antigens of Malaria ParasitesZIAAI001020 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LONG, CAROLE · 2009 to 2025
$13.6M
6 · The paper itself

Abstract

Transgenic Anopheles gambiae Giles (Diptera: Culicidae) mosquitoes have been developed that confer sexual sterility on males that carry a transgene encoding a protein which cuts ribosomal DNA. A relevant risk concern with transgenic mosquitoes is that their capacity to transmit known pathogens could be greater than the unmodified form. In this study, the ability to develop two human pathogens in these transgenic mosquitoes carrying a homing endonuclease which is expressed in the testes was compared with its nontransgenic siblings. Infections were performed with Plasmodium falciparum (Welch) and o'nyong-nyong virus (ONNV) and the results between the transgenic and nontransgenic sibling females were compared. There was no difference observed with ONNV isolate SG650 in intrathoracic infections or the 50% oral infectious dose measured at 14 d postinfection or in mean body titers. Some significant differences were observed for leg titers at the medium and highest doses for those individuals in which virus titer could be detected. No consistent difference was observed between the transgenic and nontransgenic comparator females in their ability to develop P. falciparum NF54 strain parasites. This particular transgene caused no significant effect in the ability of mosquitoes to become infected by these two pathogens in this genetic background. These results are discussed in the context of risk to human health if these transgenic individuals were present in the environment.

Indexed as

AnimalsAnimals, Genetically ModifiedAnophelesFemaleMaleMosquito VectorsO'nyong-nyong VirusPlasmodium falciparumarboviruscompetencemalariarisktransgenic

Identifiers

PMID30924861
PMCPMC6595505
OpenAlexW2931963608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.